A year after Brexit vote, European and UK shares diverge
LONDON, June 23 Another wobble in commodity-related shares saw UK bluechips extend their underperformance against continental European peers on Friday.
Dec 19 Janssen Sciences Ireland UC -
* Press release - Positive results from first Phase III studies of investigational two-drug HIV treatment regimen
* Janssen Sciences Ireland UC - Rilpivirine (Janssen) and Dolutegravir (ViiV Healthcare) met primary endpoint of non inferiority at week 48
* Janssen Sciences Ireland UC - Anticipated that regulatory submissions for Rilpivirine and Dolutegravir as a single tablet will be made in 2017 Source text for Eikon: Further company coverage:
* Kawasaki Kisen drops after board members approved as planned
* S.Korea's Moon says engagement must be backed by strong defense